Proveris Scientific UK Limited Grows Operations

Company Names European Commercial Manager, Adds Staff and Expands its Training Facility

CHICHESTER, England--(BUSINESS WIRE)--Proveris Scientific UK Limited (www.proveris.com) announced today that it has taken key steps to enlarge its operations and further execute on its commitment to serving the orally inhaled and spray drug product markets in Europe and Asia.

“Ivan joined us after establishing an impressive track record of success within the industry and has demonstrated his expertise and unwavering commitment to excellence each day since”

As one part of its growth initiative, the company has hired a new field service engineer dedicated to supporting and training customers located throughout Europe and Asia. This investment in local resources better positions Proveris to deliver exceptional service to customers who are in the production stages with their respective products.

Proveris has also promoted Mr. Ivan Prince to the position of European Commercial Manager. In this new role, Mr. Prince will apply his extensive knowledge of inhaled drug development to lead Proveris’ product application plans and manage the day-to-day operations of the UK headquarters.

“Ivan joined us after establishing an impressive track record of success within the industry and has demonstrated his expertise and unwavering commitment to excellence each day since,” said Dr. Zachary Pitluk, Chief Commercial Officer of Proveris Scientific Corporation and a Director of Proveris Scientific UK Limited. “We are pleased to announce his promotion and the integral part he will play in helping the company continue to grow the orally inhaled and spray drug product market across the globe.”

In addition to building upon its local team, the company has dedicated financial resources to expanding its training center and repair capabilities. Proveris will provide a hands-on support facility for its European and Asian customer base by installing a variety of the company’s industry leading instrument platforms at the UK headquarters office by the end of this year.

“We have experienced a significant increase in business from European and Asian customers seeking support for their growing markets. Our UK expansion is crucial to providing the high quality of service and world-class support that each of our customers has come to rely upon,” said Mr. Dino Farina, CEO of Proveris Scientific Corporation and a Director of Proveris Scientific UK, Limited. “We are proud partners of established companies like Malvern Instruments Ltd. and Aptar Pharma, and we look forward to ensuring that our customers continue to gain the greatest return on their investments in our solutions.”

About Proveris Scientific UK Limited

Proveris Scientific UK Limited is a wholly-owned subsidiary of Proveris Scientific Corporation. Proveris streamlines complex development and release testing processes of orally inhaled pharmaceutical and nasal drug products by providing complete solutions that reduce overall lab testing time by at least 100-fold compared to manual analysis. Since its inception in 1995, the company has deployed its solutions at more than 100 pharmaceutical development and manufacturing sites around the globe. Proveris’ solutions are used by the FDA and the pharmaceutical industry to set testing standards and generate robust data for their respective applications. Proveris is certified to ISO 9001:2008 by TUV Rheinland of North America and has more than 20 patents on its technology issued in United States, Europe and Asia. For more information, please visit www.proveris.com.